SCLERODERMA SYSTEMIC
Clinical trials for SCLERODERMA SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA SYSTEMIC trials appear
Sign up with your email to follow new studies for SCLERODERMA SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to halt progression of Hard-to-Treat 'Hard Skin' disease
Disease control CompletedThis study tested whether a new oral medication called BI 685509 could help control progressive systemic sclerosis, also known as scleroderma. Over 200 adults with active disease took either the drug or a placebo pill three times daily for at least 11 months. Researchers measured…
Matched conditions: SCLERODERMA SYSTEMIC
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Researchers examine which hand suffers more in scleroderma
Knowledge-focused CompletedThis study aimed to understand how scleroderma affects hand function differently between a person's dominant and non-dominant hand. Researchers measured joint movement, skin tightness, and pain in 30 adults with scleroderma. The goal was to gather basic information to help improv…
Matched conditions: SCLERODERMA SYSTEMIC
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Scientists probe immune cells to unlock Scleroderma's scarring secrets
Knowledge-focused CompletedThis study aimed to understand how a type of immune cell, called B lymphocytes, might contribute to the scarring (fibrosis) seen in systemic sclerosis (scleroderma). Researchers compared cells from 71 people, including patients and healthy volunteers, to see how patient B cells i…
Matched conditions: SCLERODERMA SYSTEMIC
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC